The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Brand Drugs-Global Market Insights and Sales Trends 2024
Synopsis
A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
The global Brand Drugs market size is expected to reach US$ 1507000 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of Brand Drugs in various end use industries. The expanding demands from the Hospital, Clinic and Other, are propelling Brand Drugs market. Biopharmaceutical, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemistry Medicine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Brand Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Brand Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Brand Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Brand Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Brand Drugs covered in this report include Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline (GSK), etc.
The global Brand Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Takeda
Global Brand Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Brand Drugs market, Segment by Type:
Biopharmaceutical
Chemistry Medicine
Global Brand Drugs market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Brand Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
The global Brand Drugs market size is expected to reach US$ 1507000 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of Brand Drugs in various end use industries. The expanding demands from the Hospital, Clinic and Other, are propelling Brand Drugs market. Biopharmaceutical, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemistry Medicine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Brand Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Brand Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Brand Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Brand Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Brand Drugs covered in this report include Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline (GSK), etc.
The global Brand Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Takeda
Global Brand Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Brand Drugs market, Segment by Type:
Biopharmaceutical
Chemistry Medicine
Global Brand Drugs market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Brand Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Brand Drugs
1.1 Brand Drugs Market Overview
1.1.1 Brand Drugs Product Scope
1.1.2 Brand Drugs Market Status and Outlook
1.2 Global Brand Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Brand Drugs Market Size by Region (2018-2029)
1.4 Global Brand Drugs Historic Market Size by Region (2018-2023)
1.5 Global Brand Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Brand Drugs Market Size (2018-2029)
1.6.1 North America Brand Drugs Market Size (2018-2029)
1.6.2 Europe Brand Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Brand Drugs Market Size (2018-2029)
1.6.4 Latin America Brand Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Brand Drugs Market Size (2018-2029)
2 Brand Drugs Market by Type
2.1 Introduction
2.1.1 Biopharmaceutical
2.1.2 Chemistry Medicine
2.2 Global Brand Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Brand Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Brand Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Brand Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Brand Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Brand Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Brand Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Brand Drugs Revenue Breakdown by Type (2018-2029)
3 Brand Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Other
3.2 Global Brand Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Brand Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Brand Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Brand Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Brand Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Brand Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Brand Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Brand Drugs Revenue Breakdown by Application (2018-2029)
4 Brand Drugs Competition Analysis by Players
4.1 Global Brand Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Brand Drugs as of 2022)
4.3 Date of Key Players Enter into Brand Drugs Market
4.4 Global Top Players Brand Drugs Headquarters and Area Served
4.5 Key Players Brand Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Brand Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Brand Drugs Products, Services and Solutions
5.1.4 Pfizer Brand Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Brand Drugs Products, Services and Solutions
5.2.4 Roche Brand Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Sanofi
5.3.1 Sanofi Profile
5.3.2 Sanofi Main Business
5.3.3 Sanofi Brand Drugs Products, Services and Solutions
5.3.4 Sanofi Brand Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson Brand Drugs Products, Services and Solutions
5.4.4 Johnson & Johnson Brand Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson & Johnson Recent Developments
5.5 Merck & Co. (MSD)
5.5.1 Merck & Co. (MSD) Profile
5.5.2 Merck & Co. (MSD) Main Business
5.5.3 Merck & Co. (MSD) Brand Drugs Products, Services and Solutions
5.5.4 Merck & Co. (MSD) Brand Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Merck & Co. (MSD) Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis Brand Drugs Products, Services and Solutions
5.6.4 Novartis Brand Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Novartis Recent Developments
5.7 AbbVie
5.7.1 AbbVie Profile
5.7.2 AbbVie Main Business
5.7.3 AbbVie Brand Drugs Products, Services and Solutions
5.7.4 AbbVie Brand Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 AbbVie Recent Developments
5.8 Gilead Sciences
5.8.1 Gilead Sciences Profile
5.8.2 Gilead Sciences Main Business
5.8.3 Gilead Sciences Brand Drugs Products, Services and Solutions
5.8.4 Gilead Sciences Brand Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Gilead Sciences Recent Developments
5.9 GlaxoSmithKline (GSK)
5.9.1 GlaxoSmithKline (GSK) Profile
5.9.2 GlaxoSmithKline (GSK) Main Business
5.9.3 GlaxoSmithKline (GSK) Brand Drugs Products, Services and Solutions
5.9.4 GlaxoSmithKline (GSK) Brand Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 GlaxoSmithKline (GSK) Recent Developments
5.10 Amgen
5.10.1 Amgen Profile
5.10.2 Amgen Main Business
5.10.3 Amgen Brand Drugs Products, Services and Solutions
5.10.4 Amgen Brand Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Amgen Recent Developments
5.11 AstraZeneca
5.11.1 AstraZeneca Profile
5.11.2 AstraZeneca Main Business
5.11.3 AstraZeneca Brand Drugs Products, Services and Solutions
5.11.4 AstraZeneca Brand Drugs Revenue (US$ Million) & (2018-2023)
5.11.5 AstraZeneca Recent Developments
5.12 Bristol-Myers Squibb
5.12.1 Bristol-Myers Squibb Profile
5.12.2 Bristol-Myers Squibb Main Business
5.12.3 Bristol-Myers Squibb Brand Drugs Products, Services and Solutions
5.12.4 Bristol-Myers Squibb Brand Drugs Revenue (US$ Million) & (2018-2023)
5.12.5 Bristol-Myers Squibb Recent Developments
5.13 Eli Lilly
5.13.1 Eli Lilly Profile
5.13.2 Eli Lilly Main Business
5.13.3 Eli Lilly Brand Drugs Products, Services and Solutions
5.13.4 Eli Lilly Brand Drugs Revenue (US$ Million) & (2018-2023)
5.13.5 Eli Lilly Recent Developments
5.14 Teva
5.14.1 Teva Profile
5.14.2 Teva Main Business
5.14.3 Teva Brand Drugs Products, Services and Solutions
5.14.4 Teva Brand Drugs Revenue (US$ Million) & (2018-2023)
5.14.5 Teva Recent Developments
5.15 Bayer
5.15.1 Bayer Profile
5.15.2 Bayer Main Business
5.15.3 Bayer Brand Drugs Products, Services and Solutions
5.15.4 Bayer Brand Drugs Revenue (US$ Million) & (2018-2023)
5.15.5 Bayer Recent Developments
5.16 Novo Nordisk
5.16.1 Novo Nordisk Profile
5.16.2 Novo Nordisk Main Business
5.16.3 Novo Nordisk Brand Drugs Products, Services and Solutions
5.16.4 Novo Nordisk Brand Drugs Revenue (US$ Million) & (2018-2023)
5.16.5 Novo Nordisk Recent Developments
5.17 AbbVie
5.17.1 AbbVie Profile
5.17.2 AbbVie Main Business
5.17.3 AbbVie Brand Drugs Products, Services and Solutions
5.17.4 AbbVie Brand Drugs Revenue (US$ Million) & (2018-2023)
5.17.5 AbbVie Recent Developments
5.18 Takeda
5.18.1 Takeda Profile
5.18.2 Takeda Main Business
5.18.3 Takeda Brand Drugs Products, Services and Solutions
5.18.4 Takeda Brand Drugs Revenue (US$ Million) & (2018-2023)
5.18.5 Takeda Recent Developments
5.19 Boehringer Ingelheim
5.19.1 Boehringer Ingelheim Profile
5.19.2 Boehringer Ingelheim Main Business
5.19.3 Boehringer Ingelheim Brand Drugs Products, Services and Solutions
5.19.4 Boehringer Ingelheim Brand Drugs Revenue (US$ Million) & (2018-2023)
5.19.5 Boehringer Ingelheim Recent Developments
5.20 Takeda
5.20.1 Takeda Profile
5.20.2 Takeda Main Business
5.20.3 Takeda Brand Drugs Products, Services and Solutions
5.20.4 Takeda Brand Drugs Revenue (US$ Million) & (2018-2023)
5.20.5 Takeda Recent Developments
6 North America
6.1 North America Brand Drugs Market Size by Country (2018-2029)
6.2 the United States
6.3 Canada
7 Europe
7.1 Europe Brand Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Brand Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Brand Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Brand Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Brand Drugs Market Dynamics
11.1 Brand Drugs Industry Trends
11.2 Brand Drugs Market Drivers
11.3 Brand Drugs Market Challenges
11.4 Brand Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
